Ronald D. Geraty, MD, CEO, Alere Medical, Inc.
Ronald Geraty, MD, says Alere is now the second-largest health management company in the industry.
Ronald D. Geraty, MD
CEO, Alere
Reno, Nev.
Deviating from the usual DM approach of randomly calling individuals to identify who needs help, enrolling them in a DM program and providing assistance, Alere relies on aggregate data from many sources to find who is at risk. Its programs integrate biometric screenings and monitoring, as exemplified by the Alere Heart Failure Program. The program puts a monitor in a patient's home to track weight and heart failure symptoms and relays actionable and real-time information to physicians. "We use technological solutions to help people better manage their health by communicating with patients several times a day through a variety of touch points," Dr. Geraty says.
Prior to joining Alere, Dr. Geraty served as CEO of American Imaging Management and was a Research Fellow at the Division of Healthcare Policy and Research at Harvard Medical School. He holds a medical degree from Loma Linda University in Loma Linda, Calif.
He was also named a Managed Healthcare Executive Leader in Disease Management in 2004.
Why Patient Registries Need to Make the Move From Tactical to Strategic Research Initiatives
September 6th 2022The one-sided, research-oriented approach has to change so patients have ready access to dashboards with their disease histories and pre-visit documents tailored to the patient questions.
Read More
Study: Patients with High Deductible Plans More Likely to Delay Care
September 7th 2021Patients faced with high out-of-pocket costs sometimes delay seeking care for appendicitis or diverticulitis, which can result in higher overall costs, increased risk of mortality, and a worse quality of life.
Read More
